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Basal cell carcinoma (BCC) is the most common
malignant skin tumor amongwhites.1 More than 80%
of BCCs are found on photo-exposed areas,
predominantly on the head and the neck. More
uncommonly, BCC may appear on nonesun-
exposed areas or on areas with chronic inflamma-
tion, scars, burns or skin grafts.2-8
CASE REPORT
Wepresent the case of a white 58-year-old woman
with skin phototype III (Fitzpatrick scale) who
suffered a second- to third-degree burn in childhood
on the external surface of her right arm. A
full-thickness skin graft, obtained from the internal
surface of her right thigh, was used for the repair. The
patient complained of a 3-year history of skin lesions
that progressively grew in size located on the graft
and the scar of the donor site. She denied having
regular sun exposure or previous sunburns. Family
history was noncontributory.
A dermatologic examination found 5 pink eroded
thin papules and plaques, 5 to 15 mm in size, some
with ulcerations, over the donor site of her right thigh
(Fig 1, A). On the graft recipient site on the right arm,
there was a 10- 3 4-mm violaceous papule with a
smooth surface (Fig 1, B). Biopsy specimens were
taken from both areas. Pathologic examination from
both areas found superficial multifocal BCC over foci
of actinic keratoses (Fig 2).
Surgical excision of the single lesion on the graft
recipient site was performed. The lesions on the
donor site were initially treated with 5% imiquimod
cream 5 days per week for a total of 16 weeks withthe Department of Dermatology, Hospital Universitario
vero Ochoa, Avenida de Orellana, Leganes.
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ber88@hotmail.com.partial improvement. Treatment was continued
with methyl aminolevulinate under an occlusive
dressing for 3 hours and subsequent illumination
with noncoherent red light (630 nm at a dose of
37 J/cm2) for 9 minutes, 45 seconds. After 3
monthly sessions, a 50% reduction in the size of
the lesions was observed, allowing surgical exci-
sion of all lesions. The patient underwent follow-
up for 7 years with no evidence of recurrence or
new lesions.DISCUSSION
The appearance of BCC over nonephoto-
exposed areas is an uncommon form of this tumor
with a frequency of less than 15% of all published
series.8 Although exposure to ultraviolet light is the
most important factor in the development of BCC in
photo-exposed areas,1 other predisposing factors
are involved in the development of BCC in none
photo-exposed areas: immunologic dysregulation,
chronic exposure to tar and arsenic, burns, scars,
and in areas of vaccination, tattoos, piercings, or
chronic ulcers. It has been suggested that a
decrease in vascularization and elasticity in skin
tissue makes the overlying epithelium more sus-
ceptible to repeated trauma-induced carcinogen-
esis, with a variable latency period from a few
weeks to several years.8,9JAAD Case Reports 2015;1:244-6.
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Fig 1. A, Graft donor site of the right thigh. Five red
maculopapular lesions, some with an ulceration. B, Graft
receptor site of the right arm. A papular erythematous-
purple lesion with a smooth surface.
Fig 2. Graft donor site of the right thigh. Nest of basal cells
within the epidermis and chronic inflammatory infiltrate in
the upper dermis. (Hematoxylin-eosin stain; original
magnification 34.)
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chronic inflammation is squamous cell carcinoma.
BCCmay be 3 to 7 times less frequent. Squamous cell
carcinoma in these areas has a more aggressive
clinical course, whereas BCC has a similar clinical
behavior as seen in other areas. From a histologic
point of view, the most common pathologic form
of BCC found on nonephoto-exposed areas is
nodular, followed by pigmented, adenoid, invasive,
superficial, and basosquamous.3,6,8
In 1984, Cox7 published the first case. Since then,
some isolated cases of BCC over graft sites have
been reported in the literature (Table I).2-6 The time
of BCC development from graft surgery ranged
from 1 to 60 years. The graft donor and recipient
sites are highly variable as is the thickness of the
graft. The most common subtypes of BCC findings
are nodular and superficial. Except in the first case,
treatment was surgical excision with no evidence of
recurrence or onset of new skin tumors. Different
etiopathogenic factors have been suggested by
these authors: continuous sun exposure with sun-
burns,2 previous surgical procedures, delay oftreatment of cutaneous leishmaniasis,3 transfer of
neoplastic cells from the donor site to the grafted
site,4 and proliferation of cells from the outer sheath
of the hair follicle of the grafted area caused by
regular sun exposure.5
Nevertheless, our case is unusual, as the patient
showed simultaneous onset of BCC over both the
donor and recipient sites, although this occurrence
may be a coincidence.
The patient did not have skin tumors in other
locations or a family history of them. We believe
sun exposure did not significantly influence the
etiopathogenesis of these tumors. In addition, the
patient did not have any underlying risk factors for
the development of BCC such as lymphoproliferative
diseases, solid organ transplant, or immunosuppres-
sive treatment.
We considered 2 primary etiopathogenic
possibilities: (1) de novo onset of BCC over
re-epithelialized areas of skin at the donor site
and in the burn site and subsequent graft owing to
field cancerization effect and (2) the patient may
possess an uncharacterized mutation in a tumor
suppressor gene around the graft donor site owing
to a mosaic inheritance pattern. This mutated skin
was then partially donated to a new area, and basal
cell carcinomas subsequently developed in both
areas.10
However, we are not able to establish clear
etiopathogenic factors.
Table I. Description of cases of basal cell carcinoma over graft sites
Study Sex Age, y Donor site Recipient site
Graft
thickness
Time from
surgery to
onset, y
BCC over
graft site
Cox7 Female 80 Thigh Presternal area Partial 4 Superficial
Martin et al6 Female 72 Forearm Forearm Partial 2 Nodular
Invasive
Karri et al5 Female 52 Left thigh Right thigh Partial 30 Type not
specified
Lemierre et al4 Female 73 Left inguinal fold Right mandibular
angle
Partial 1 Nodular
Yazici et al3 Female 75 Thigh Upper eyelid Full 61 Nodular
Angelos et al2 Male 50 Lateral thigh Scalp Partial 31 Invasive
JAAD CASE REPORTS
SEPTEMBER 2015
246 Imbernon-Moya et alREFERENCES
1. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H.
Epidemiology and aetiology of basal cell carcinoma. Br J
Dermatol. 2007;157(Suppl 2):47-51.
2. Angelos TM, Larsen MT, Janz BA. Nodular Basal cell carcinoma
arising in a split-thickness skin graft of the scalp. Ann Plast
Surg. 2013;71(4):372-374.
3. Yazici B, Gonen T, UcanG. Basal cell carcinoma in a full-thickness
skin graft in the upper eyelid. Orbit. 2011;30(5):255-257.
4. Lemierre G, Bony-Rerolle S, El-Haite A, Auquit-Auckbur I,
Milliez PY. [Recurrence of a basal cell carcinoma in a skin graft
in spite of total excision. A case report]. Ann Chir Plast Esthet.
2007;52(1):71-74.
5. Karri V, Dheansa B, Moss T. Basal cell carcinoma arising in a
split skin graft. Br J Plast Surg. 2005;58(2):276-277.6. Martin JM, Monteagudo C, Alonso V, et al. Basal cell
carcinomas arising on a skin graft secondary to a thermal
burn scar. Burns. 2005;31(6):789-791.
7. Cox NH. Basal cell carcinoma in a skin graft recipient site.
Practitioner. 1984;228(1397):997-998.
8. Park J, Cho YS, Song KH, Lee JS, Yun SK, Kim HU. Basal cell
carcinoma on the pubic area: Report of a case and review of
19 korean cases of BCC from non-sun-exposed areas. Ann
Dermatol. 2011;23(3):405-408.
9. Youssef KK, Van Keymeulen A, Lapouge G, et al. Identification
of the cell lineage at the origin of basal cell carcinoma. Nat Cell
Biol. 2010;12(3):299-305.
10. Asplund A, Sivertsson A, B€ackvall H, Ahmadian A, Lundeberg J,
Ponten F. Genetic mosaicism in basal cell carcinoma. Exp
Dermatol. 2005;14:593-600.
